Загрузка...
Relapsing-Remitting Multiple Sclerosis Patients' Experience with Natalizumab: A Phenomenological Investigation
This phenomenological investigation was undertaken to gain a better understanding of multiple sclerosis (MS) patients' experience with natalizumab (Tysabri; Biogen Idec Inc, Cambridge, MA) treatment and its impact on their quality of life (QOL). Twenty MS patients who were receiving natalizumab...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Consortium of Multiple Sclerosis Centers
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882975/ https://ncbi.nlm.nih.gov/pubmed/24453731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.39 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|